<rss version="2.0">
<channel>
	<title>Neurokin</title>
	<link>http://www.neurokin.com/</link>
	<description></description>
			<item>
		<title>Biotechnology Company NEUROKIN Strengthens its Board of Directors and Scientific Committee</title>
		<description><img src="http://www.neurokin.com/all.gif" />The neuroprotective drugs development company announces today the appointment of  two former Vice Presidents of Sanofi - Aventis; Bernard Reculeau, and Jesús Benavides.</description>
		<link>http://www.neurokin.com/neuroprotection/biotechnology-company-neurokin-strengthens-its-board-of-directors-and-scientific-committee-14822810.html</link>
		<guid>http://www.neurokin.com/neuroprotection/biotechnology-company-neurokin-strengthens-its-board-of-directors-and-scientific-committee-14822810.html</guid>
		<pubDate>Thu, 28 Oct 2010 08:14:58 +0000</pubDate>
	</item>
		<item>
		<title>NEUROKIN accentuates its leadership in the treatment of acute neurological diseases</title>
		<description>The Company strengthens its intellectual property with the grant of European patent on its most advanced
drug candidate NK-102.</description>
		<link>http://www.neurokin.com/neuroprotection/neurokin-accentuates-its-leadership-in-the-treatment-of-acute-neurological-diseases-1439309.html</link>
		<guid>http://www.neurokin.com/neuroprotection/neurokin-accentuates-its-leadership-in-the-treatment-of-acute-neurological-diseases-1439309.html</guid>
		<pubDate>Thu, 30 Sep 2010 14:20:22 +0000</pubDate>
	</item>
		<item>
		<title>Neurokin scientifically recognized with a publication in the PLoS One Revue</title>
		<description>The significant results obtained by NEUROKIN were published in August by the PLoS One Revue in an article entitled: « Delayed Treatment with Systemic (S)-Roscovitine Provides Neuroprotection and Inhibits In Vivo CDK5 Activity Increase in Animal Stroke Models »*.

Bénédicte Menn et al., PLoS ONE, August 2010, volume 5, issue 8.</description>
		<link>http://www.neurokin.com/neuroprotection/neurokin-scientifically-recognized-with-a-publication-in-the-plos-one-revue-1438309.html</link>
		<guid>http://www.neurokin.com/neuroprotection/neurokin-scientifically-recognized-with-a-publication-in-the-plos-one-revue-1438309.html</guid>
		<pubDate>Thu, 30 Sep 2010 14:09:21 +0000</pubDate>
	</item>
		<item>
		<title>New patent granted to Neurokin by the European Patent Office</title>
		<description>Neurokin&#039;s patent EP 1 998 778 has been granted.</description>
		<link>http://www.neurokin.com/neuroprotection/new-patent-granted-to-neurokin-by-the-european-patent-office-1437309.html</link>
		<guid>http://www.neurokin.com/neuroprotection/new-patent-granted-to-neurokin-by-the-european-patent-office-1437309.html</guid>
		<pubDate>Thu, 30 Sep 2010 13:37:36 +0000</pubDate>
	</item>
		<item>
		<title>Neurokin launches updated website</title>
		<description>Neurokin launches updated website.</description>
		<link>http://www.neurokin.com/neuroprotection/neurokin-launches-updated-website-457175.html</link>
		<guid>http://www.neurokin.com/neuroprotection/neurokin-launches-updated-website-457175.html</guid>
		<pubDate>Sun, 17 May 2009 20:03:23 +0000</pubDate>
	</item>
		</channel>
</rss>
